Cargando…

From Sequence Data to Patient Result: A Solution for HIV Drug Resistance Genotyping With Exatype, End to End Software for Pol-HIV-1 Sanger Based Sequence Analysis and Patient HIV Drug Resistance Result Generation

INTRODUCTION: With the rapid scale-up of antiretroviral therapy (ART) to treat HIV infection, there are ongoing concerns regarding probable emergence and transmission of HIV drug resistance (HIVDR) mutations. This scale-up has to lead to an increased need for routine HIVDR testing to inform the clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kingwara, Leonard, Karanja, Muthoni, Ngugi, Catherine, Kangogo, Geoffrey, Bera, Kipkerich, Kimani, Maureen, Bowen, Nancy, Abuya, Dorcus, Oramisi, Violet, Mukui, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536479/ https://www.ncbi.nlm.nih.gov/pubmed/32990139 http://dx.doi.org/10.1177/2325958220962687

Ejemplares similares

Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
por: Parkin, Neil T., et al.
Publicado: (2020)

Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance
por: Novitsky, V., et al.
Publicado: (2022)

Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data
por: Karanja, Muthoni, et al.
Publicado: (2020)

Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
por: Telele, Nigus Fikrie, et al.
Publicado: (2018)

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
por: Jennings, Cheryl, et al.
Publicado: (2020)

Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments
por: Arias, Andrea, et al.
Publicado: (2018)

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure
por: Mohamed, Sofiane, et al.
Publicado: (2014)

HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China
por: Li, Qun, et al.
Publicado: (2022)

“I feel drug resistance testing allowed us to make an informed decision”: qualitative insights on the role of HIV drug resistance mutation testing among children and pregnant women living with HIV in western Kenya
por: Scallon, Andrea J., et al.
Publicado: (2023)

HIV Transmission Rates and Factors Associated with Recent HIV Infection: Results from the Ndhiwa HIV Impact Assessment, South Nyanza, Kenya, 2012
por: Agyemang, Elfriede, et al.
Publicado: (2017)

Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000–2014
por: Moscona, Roy, et al.
Publicado: (2017)

HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
por: Geretti, Anna Maria, et al.
Publicado: (2022)

Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA
por: Tumiotto, Camille, et al.
Publicado: (2017)

SangeR: the high-throughput Sanger sequencing analysis pipeline
por: Schmid, Kai, et al.
Publicado: (2022)

A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients
por: Kagan, Ron M., et al.
Publicado: (2012)

qSanger: Quantification of Genetic Variants in Bacterial Cultures by Sanger Sequencing
por: Prakash, Satya, et al.
Publicado: (2023)

Ending the HIV/AIDS Pandemic
por: Eisinger, Robert Walter, et al.
Publicado: (2018)

Mortuary and hospital-based HIV mortality surveillance among decedents in a low-resource setting: lessons from Western Kenya
por: Nyakeriga, Emmanuel, et al.
Publicado: (2022)

A2 Optimization of the results generated by large-scale sequencing for the study of drug resistance in HIV infection: A systematic review
por: Fernández-Caballero, J A, et al.
Publicado: (2018)

Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania
por: Juma, James M, et al.
Publicado: (2014)

Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
por: Pilgrim, Nanlesta A., et al.
Publicado: (2018)

A Comparison of Parallel Pyrosequencing and Sanger Clone-Based Sequencing and Its Impact on the Characterization of the Genetic Diversity of HIV-1
por: Liang, Binhua, et al.
Publicado: (2011)

Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)
por: Patel, Rena C., et al.
Publicado: (2023)

The transmission of drug-resistant strains of HIV in heterosexual populations based on genetic sequences
por: Jin, Xin, et al.
Publicado: (2021)

Analysis of transmitted HIV-1 drug resistance using 454 ultra-deep-sequencing and the DeepChek(®)-HIV system
por: Garcia-Diaz, Ana, et al.
Publicado: (2014)

Phylogenetic and Drug-Resistance Analysis of HIV-1 Sequences From an Extensive Paediatric HIV-1 Outbreak in Larkana, Pakistan
por: Abidi, Syed Hani, et al.
Publicado: (2021)

HIV and Drug-Resistant Subtypes
por: Nastri, Bianca Maria, et al.
Publicado: (2023)

Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
por: Jarlais, Don Des, et al.
Publicado: (2022)

HIV Drug Resistance Patterns and Characteristics Associated with Clinically Significant Drug Resistance among Children with Virologic Failure on Antiretroviral Treatment in Kenya: Findings from the Opt4Kids Randomized Controlled Trial
por: Abuogi, Lisa, et al.
Publicado: (2023)

HIV-1 drug-resistance and drug-dependence
por: Baldwin, Chris, et al.
Publicado: (2007)

Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance
por: Masso, Majid, et al.
Publicado: (2013)

HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique
por: Rupérez, María, et al.
Publicado: (2018)

Drug Resistance Prediction Using Deep Learning Techniques on HIV-1 Sequence Data
por: Steiner, Margaret C., et al.
Publicado: (2020)

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020)

Probe Capture Enrichment Methods for HIV and HCV Genome Sequencing and Drug Resistance Genotyping
por: Munyuza, Chantal, et al.
Publicado: (2022)

Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia
por: Mesfin, Eyob Abera, et al.
Publicado: (2022)

1520. Exploring the factors linked to prior HIV testing and schistosomiasis treatment in Malawi.
por: Kangogo, Geoffrey K
Publicado: (2023)

A national household survey on HIV prevalence and clinical cascade among children aged ≤15 years in Kenya (2018)
por: Mutisya, Immaculate, et al.
Publicado: (2022)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

A Sequel to Sanger: amplicon sequencing that scales
por: Hebert, Paul D. N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1nik8dhct8bmgnul1mr03vob7v